Long-term cardiovascular outcomes in children and adolescents with hypertension

JAMA Pediatrics

2024-05-06

(Press-News.org) About The Study: Children diagnosed with hypertension had a higher associated long-term risk of major adverse cardiac events compared with controls without hypertension. Improved detection, follow-up, and control of pediatric hypertension may reduce the risk of adult cardiovascular disease.

Authors: Rahul Chanchlani, M.B.B.S., M.D., M.Sc., of McMaster University in Hamilton, Canada, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamapediatrics.2024.1543)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being released to coincide with presentation at the Pediatric Academic Societies meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1543?guestAccessKey=629b52f1-cf25-4fcb-86b2-cd4d43237377&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050624

END

ELSE PRESS RELEASES FROM THIS DATE:

CRIPSR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows

2024-05-06

KEY TAKEAWAYS BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy was found safe with no dose-limiting toxicities reported. Mass Eye and Ear researchers say their findings support continued research and clinical trials of CRISPR therapies for inherited retinal disorders. BOSTON- (MAY 6, 2024) Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals ...

Improvement seen in most participants of pioneering CRISPR gene editing trial

2024-05-06

PORTLAND, Oregon – About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine. “This trial shows CRISPR gene editing has exciting potential to treat inherited retinal degeneration,” said Mark Pennesi, M.D., Ph.D., a corresponding author on the paper, an ophthalmologist and Oregon Health & Science University’s lead scientist for the Phase ...

Cybersecurity education varies widely in US

2024-05-06

PULLMAN, Wash. -- Cybersecurity programs vary dramatically across the country, a review has found. The authors argue that program leaders should work with professional societies to make sure graduates are well trained to meet industry needs in a fast-changing field. In the review, published in the Proceedings of the Association for Computing Machinery’s Technical Symposium on Computer Science Education, a Washington State University-led research team found a shortage of research in evaluating the instructional approaches being used to teach cybersecurity. The authors also contend that programs ...

New vaccine effective against coronaviruses that haven’t even emerged yet

2024-05-06

Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don’t even know about. This is a new approach to vaccine development called ‘proactive vaccinology’, where scientists build a vaccine before the disease-causing pathogen even emerges. The new vaccine works by training the body’s immune system to recognise specific regions of eight different coronaviruses, including SARS-CoV-1, SARS-CoV-2, and several that are ...

Simulated chemistry: New AI platform designs tomorrow’s cancer drugs

2024-05-06

Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of drug discovery, which could significantly streamline the process and open doors for never-before-seen treatments. Identifying candidate drugs for further optimization typically involves thousands of individual experiments, but the new artificial intelligence (AI) platform could potentially give the same results in a fraction of the time. The researchers used the new tool, described in Nature Communications, to synthesize 32 new drug candidates for cancer. The technology is part of a new but growing trend ...

Human ‘neural compass’ pinpointed in new study

2024-05-06

A pattern of brain activity that helps prevent us from getting lost has been identified in a new study, published in Nature Human Behaviour. Researchers at the University of Birmingham and Ludwig Maximilian University of Munich have for the first time been able to pinpoint the location of an internal neural compass which the human brain uses to orientate itself in space and navigate through the environment. The research identifies finely tuned head direction signals within the brain. The results are comparable to neural codes identified in ...

Personalized screening early in pregnancy may improve preeclampsia detection

2024-05-06

Research Highlights: A personalized screening algorithm for preeclampsia in the first trimester of pregnancy may help clinicians better predict who is at risk for developing the condition and who may benefit from treatment with a daily, low-dose aspirin. In this study of more than 7,000 women, the new screening method, which combined maternal history, biomarker tests and ultrasound tests, was better at identifying preeclampsia risk in than current risk factor-based guidelines. Embargoed until 4 a.m. CT/5 a.m. ET Monday, May 6, 2024 DALLAS, May 6, 2024 — A new screening algorithm for preeclampsia combining maternal history, ...

Expanding a lymph node, boosting a vaccine

2024-05-06

Expanding a lymph node, boosting a vaccine A biomaterial vaccine enhances and sustains lymph node expansion following vaccination, boosting anti-tumor immunity in an animal model. By Benjamin Boettner (BOSTON) — Each one of us has around 600 lymph nodes (LNs) – small, bean-shaped organs that house various types of blood cells and filter lymph fluid – scattered throughout our bodies. Many of us have also experienced some of our LNs to temporarily swelling during infections with viruses or other pathogens. This LN expansion and subsequent contraction can also result from vaccines injected nearby, and in fact ...

GIST-MIT CSAIL researchers develop a biomechanical dataset for badminton performance analysis

2024-05-06

In sports training, practice is the key, but being able to emulate the techniques of professional athletes can take a player’s performance to the next level. AI-based personalized sports coaching assistants can make this a reality by utilizing published datasets. With cameras and sensors strategically placed on the athlete's body, these systems can track everything, including joint movement patterns, muscle activation levels, and gaze movements. Using this data, personalized feedback is provided on player technique, along with improvement recommendations. Athletes can access this feedback anytime, and anywhere, making these systems versatile for athletes at ...

Study sheds light on 11th century Arab-Muslim optical scientist whose work laid ground for modern-day physics

2024-05-06

Scientists from the University of Sharjah and the Warburg Institute are poring over the writings of an 11th century Arab-Muslim polymath to demonstrate their impact on the development of optical sciences and how they have fundamentally transformed the history of physics from the Middle Ages up to modern times in Europe. Their research focuses on the legacy of al-Ḥasan Ibn al-Haytham known in Latin as “Alhazen” and particularly his most influential work titled Book of Optics, reputed in Arabic as Kitab al-Manazir and first circulated in Europe via its Latin translation dubbed ‘Perspectiva’. Ibn ...

First experimental validation of a “150-year-old chemical common sense” direct visualization of the molecular structural changes in the ultrafast anthracene [4+4] photocycloaddition reaction

Long-term cardiovascular outcomes in children and adolescents with hypertension

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: